Hanmi creates lineup with Amosartan family, challenging annul KRW 100 million sales

Published: 2017-07-26 16:27:00
Updated: 2017-07-26 15:42:00

Hanmi Pharm(CEO Jong-Soo Woo, Sae-Chang Kwon) acquired approvals for 2 products of 2-substance combination drug containing the substance of Amosartan, the top sales product. Hanmi is planning to continue the Amosartan wave with 3 products of the ‘Amosartan family’ in the antihypertensive market.

...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.